Background: Cardiac involvement significantly impacts the prognosis of sarcoidosis. While conduction abnormalities represent the classic presentation, inaugural acute heart failure with severe left ventricular dysfunction is a less common and diagnostically challenging phenotype...
Open access
Research Article10.9734/ca/2026/v15i3549
Background: Cardiovascular disease accounts for approximately 45% of all-cause mortality in hemodialysis patients — a risk 10 to 20 times higher than in the general population. Despite the critical role of echocardiography in characterizing this cardiac burden, systematic echocar...
Open access
Research Article10.9734/ca/2026/v15i3548
Introduction: Sarcomeric hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease. Its prognosis is primarily determined by the risk of ventricular arrhythmias and sudden cardiac death (SCD). This study aimed to describe the rhythm profile of patients with sar...
Open access
Research Article10.9734/ca/2026/v15i3547
Mariana Elizabeth Colón Navar, Héctor Raúl Ibarra Sifuentes, Uvane Andrea Cu Farfán Sánchez, Juan Jaime Saldívar Salazar, Ana Karen Oyarvide Zapuche, Alicia Estefanía Cantú González, Raymundo Garay García, Carlos Zarick Sáenz Tapia & Carlos Alberto Ponce López·Cardiology and Angiology: An International Journal·2026
Background: Acute ischemic heart disease causes myocardial infarction due to obstruction blood flow in coronary arteries caused by accumulation atherosclerotic plaque. Heart failure is frequent complication when coronary intervention is not performed, increasing risk of mortality...
Open access
Research Article10.9734/ca/2026/v15i2546
Background: Infective endocarditis (IE) associated with implantable cardiac devices (ICDs): pacemakers, automatic defibrillators, and cardiac resynchronisation therapy devices, is a rare but serious complication with a high mortality rate despite therapeutic advances. The steady...
Open access
Research Article10.9734/ca/2026/v15i2544
Background: Heart failure with reduced ejection fraction (HFrEF) is a leading cause of cardiovascular mortality and morbidity worldwide. Optimized pharmacological therapy — comprising the four pillars of neurohormonal blockade (ACE inhibitors/ARBs, beta-blockers, MRA, SGLT2i) — h...
Open access
Research Article10.9734/ca/2026/v15i2545
Background: Heart failure with reduced ejection fraction (HFrEF) represents a growing global public health burden, particularly in low- and middle-income countries where cardiovascular risk factors are prevalent and undercontrolled. Data from North Africa and Morocco remain scarc...
Open access
Research Article10.9734/ca/2026/v15i2542
Background: The etiological distribution of heart failure with reduced ejection fraction (HFrEF) varies significantly across regions, reflecting differences in cardiovascular risk factor prevalence, genetic predisposition, and healthcare access. Data from North African military p...
Open access
Research Article10.9734/ca/2026/v15i2543
Background: Vitamin K antagonist (VKA)-induced skin necrosis is a rare but life-threatening complication, typically occurring during the initiation phase of anticoagulation therapy. Its disseminated presentation is exceptional and poses a major diagnostic and therapeutic challeng...
Open access
Research Article10.9734/ca/2026/v15i2541
Background: Papillary muscle rupture (PMR) is a rare but rapidly fatal mechanical complication of acute myocardial infarction (MI) that may occur even after apparently limited ischemia. In the contemporary reperfusion era, its incidence is estimated between 0.05% and 0.26% of MIs...
Open access
Research Article10.9734/ca/2026/v15i2540